A molecular docking study repurposes FDA approved iron oxide nanoparticles to treat and control COVID-19 infection

2020235 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: European Journal of Pharmaceutical Sciences

Volume 153, pp. 105465-105465

Field-Weighted Citation Impact: 4.81